Interpretation and commenting on clinical chemistry results

Articles in the same Issue

1. Frontmatter
2. Committees
3. Contents
4. Invited Speakers Abstracts
5. Laboratory Reference Intervals: Global Initiatives and Harmonization Challenges
6. Applying Big Data in the Improvement of Laboratory Practice
7. Affordable diagnostics for Africa
8. Risk Management and its utility in the clinical laboratory
9. Recent advances in standardisation
10. Plenary Lecture
11. Liquid Biopsy: circulating plasma free DNA (cfDNA) as a novel prognostic and diagnostic marker in disease states
12. Frontiers in endocrinology
13. Biomarkers in urological cancer
14. Evidenced Based Laboratory Medicine (EBLM); a global perspective
15. Genomic analysis in personalized diagnostics
16. Pre-analytical quality work in medical labs
17. Role of biomarkers in precision medicine
18. Biomarkers in clinical chemistry - The omics galaxies
19. Clinical Endocrinology
20. Dengue Chicungunya and Zika impact and interventions in Latin American countries
21. Clinical Laboratory practice for bone turnover markers
22. Advances in TB diagnostics
23. Traceability in laboratory medicine: what is it and why is it important?
24. Practical aspects of taking laboratory to next step
25. Development of a Clinical Case Bank for Promoting the Practice of EBLM
26. Value of laboratory medicine in healthcare delivery
27. Advanced glycation end products (AGES) in diabetes mellitus and chronic diseases
28. Facing the future of Alzheimer’s disease: the value of the medical laboratory
29. Training programs for biomedical scientists laboratory medicine specialists
30. Interpretation and commenting on clinical chemistry results
31. The porphyrias: from clinical presentation to a diagnosis. The role of the laboratory profession
32. Emerging challenges of laboratory medicine
33. Big data and metabolomics in pediatric laboratory medicine
34. Circulating tumor markers: an update
35. Standardization in laboratory medicine beyond clinical chemistry
36. Bridging the gaps between laboratory medicine & clinical decision making: challenges and conundrums: an interactive workshop
37. ISO accreditation and quality assurance
38. Improvement in clinical laboratory services: approaches to adding value
39. The evolution of lab medicine in the Arabic countries
40. Closing Lecture
41. Educational Workshop Abstracts
42. Poster Abstracts
43. Advanced Glycation End Products (AGEs) in diabetes mellitus and chronic disease
44. Advances in TB diagnostics
45. Affordable diagnostics for Africa
46. Alzheimer’s Disease
47. Applying big Data to Improve Laboratory Practice
48. Big data and metabolomics
49. Biomarkers in cancer/ Circulating tumour markers
50. Biomarkers in precision medicine
51. Bridging the gaps between laboratory medicine and clinical decision making: challenges and conundrums
52. Clinical Laboratory Practice for Bone Turnover markers
53. Emerging challenges of Laboratory Medicine
54. Evidence-based laboratory medicine
55. Frontiers in endocrinology
56. High sensitivity cardiac troponin assays
57. HIV
58. Implementing Cancer Genomics in Low Resource Settings
59. Improvement in clinical laboratory services: Approaches to adding value
60. Infections and diabetes
61. Interpretation and Commenting on Clinical Chemistry Results: An interactive workshop
62. ISO accreditation and quality assurance
63. Laboratory Reference Intervals: Global Initiatives and Harmonization challenges
64. Liquid biopsy and circulating free plasma DNA
65. Metabolomics and biomarkers
66. Miscellaneous
67. Personalized and precision medicine
68. Porphyrias
69. Pre and Post analytical quality
70. Risk Management and its utility in the clinical laboratory
71. Standardization in laboratory medicine beyond clinical chemistry
72. Strategic Planning for Evaluation and Assessment of Internal and External quality control Performance
73. Traceability in laboratory medicine
74. Training programmes for biomedical scientists and laboratory medicine specialist
75. Value of Laboratory Medicine in Healthcare Delivery